These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 17174418)
1. Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertension. Chau EM; Fan KY; Chow WH Int J Cardiol; 2007 Sep; 120(3):301-5. PubMed ID: 17174418 [TBL] [Abstract][Full Text] [Related]
2. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship. Garg N; Sharma MK; Sinha N Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417 [TBL] [Abstract][Full Text] [Related]
3. Sildenafil therapy for pulmonary arterial hypertension associated with atrial septal defects. Lim ZS; Salmon AP; Vettukattil JJ; Veldtman GR Int J Cardiol; 2007 May; 118(2):178-82. PubMed ID: 17027100 [TBL] [Abstract][Full Text] [Related]
4. Oral sildenafil treatment for Eisenmenger syndrome: a prospective, open-label, multicentre study. Zhang ZN; Jiang X; Zhang R; Li XL; Wu BX; Zhao QH; Wang Y; Dai LZ; Pan L; Gomberg-Maitland M; Jing ZC Heart; 2011 Nov; 97(22):1876-81. PubMed ID: 21948962 [TBL] [Abstract][Full Text] [Related]
6. The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension. Bharani A; Mathew V; Sahu A; Lunia B Indian Heart J; 2003; 55(1):55-9. PubMed ID: 12760589 [TBL] [Abstract][Full Text] [Related]
7. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology. D'Alto M; Romeo E; Argiento P; Sarubbi B; Santoro G; Grimaldi N; Correra A; Scognamiglio G; Russo MG; Calabrò R Int J Cardiol; 2012 Mar; 155(3):378-82. PubMed ID: 21081251 [TBL] [Abstract][Full Text] [Related]
8. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension. Singh TP; Rohit M; Grover A; Malhotra S; Vijayvergiya R Am Heart J; 2006 Apr; 151(4):851.e1-5. PubMed ID: 16569546 [TBL] [Abstract][Full Text] [Related]
9. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618 [TBL] [Abstract][Full Text] [Related]
10. Sildenafil therapy in secondary pulmonary hypertension: Is there benefit in prolonged use? Chapman TH; Wilde M; Sheth A; Madden BP Vascul Pharmacol; 2009; 51(2-3):90-5. PubMed ID: 19386283 [TBL] [Abstract][Full Text] [Related]
11. One year efficacy and safety of oral sildenafil treatment in severe pulmonary hypertension. Samarzija M; Zuljević E; Jakopović M; Sever B; Knezević A; Dumija Z; Vidjak V; Samija M Coll Antropol; 2009 Sep; 33(3):799-803. PubMed ID: 19860106 [TBL] [Abstract][Full Text] [Related]
12. Management of Eisenmenger syndrome in pregnancy with sildenafil and L-arginine. Lacassie HJ; Germain AM; Valdés G; Fernández MS; Allamand F; López H Obstet Gynecol; 2004 May; 103(5 Pt 2):1118-20. PubMed ID: 15121629 [TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of sildenafil in Eisenmenger's syndrome secondary to atrial septal defect versus ventricular septal defect: a cardiac catheterisation follow-up study. Garg N; Tripathy N; Sinha N Cardiol Young; 2011 Dec; 21(6):631-8. PubMed ID: 21729508 [TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: a preliminary observational study. Mukhopadhyay S; Sharma M; Ramakrishnan S; Yusuf J; Gupta MD; Bhamri N; Trehan V; Tyagi S Circulation; 2006 Oct; 114(17):1807-10. PubMed ID: 17030688 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension. Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071 [TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of sildenafil in Chinese patients with pulmonary arterial hypertension. Xu XQ; Jing ZC; Zhang JH; Wu Y; Wang Y; Jiang X; Wang ZX; Sun YG; Pu JL; Yang YJ Hypertens Res; 2009 Oct; 32(10):911-5. PubMed ID: 19644505 [TBL] [Abstract][Full Text] [Related]
18. Sildenafil for pulmonary hypertension secondary to congenital heart diseases. Gupta A; Kerkar P Indian Heart J; 2007; 59(4):342-5. PubMed ID: 19126940 [TBL] [Abstract][Full Text] [Related]
19. Effect of oral sildenafil citrate on intraoperative hemodynamics in patients with pulmonary hypertension undergoing valvular heart surgery. Shim JK; Choi YS; Oh YJ; Kim DH; Hong YW; Kwak YL J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1420-5. PubMed ID: 17140970 [TBL] [Abstract][Full Text] [Related]
20. Effects of pulmonary vasodilator therapy on ventilatory efficiency during exercise in adults with Eisenmenger syndrome. Yang-Ting S; Aboulhosn J; Sun XG; Child JS; Sietsema KE Congenit Heart Dis; 2011; 6(2):139-46. PubMed ID: 21418531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]